[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT202200001853A1 - Composizioni probiotiche e loro uso per modulare l'attività infiammatoria di tipo allergico - Google Patents

Composizioni probiotiche e loro uso per modulare l'attività infiammatoria di tipo allergico Download PDF

Info

Publication number
IT202200001853A1
IT202200001853A1 IT102022000001853A IT202200001853A IT202200001853A1 IT 202200001853 A1 IT202200001853 A1 IT 202200001853A1 IT 102022000001853 A IT102022000001853 A IT 102022000001853A IT 202200001853 A IT202200001853 A IT 202200001853A IT 202200001853 A1 IT202200001853 A1 IT 202200001853A1
Authority
IT
Italy
Prior art keywords
inflammatory activity
probiotic compositions
type inflammatory
modulate allergic
allergic
Prior art date
Application number
IT102022000001853A
Other languages
English (en)
Inventor
Rosella Malanchin
Cristiana Piangiolino
Silvia Castegnaro
Patrizia Malfa
Original Assignee
Synbalance Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synbalance Srl filed Critical Synbalance Srl
Priority to IT102022000001853A priority Critical patent/IT202200001853A1/it
Publication of IT202200001853A1 publication Critical patent/IT202200001853A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
IT102022000001853A 2022-02-03 2022-02-03 Composizioni probiotiche e loro uso per modulare l'attività infiammatoria di tipo allergico IT202200001853A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102022000001853A IT202200001853A1 (it) 2022-02-03 2022-02-03 Composizioni probiotiche e loro uso per modulare l'attività infiammatoria di tipo allergico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000001853A IT202200001853A1 (it) 2022-02-03 2022-02-03 Composizioni probiotiche e loro uso per modulare l'attività infiammatoria di tipo allergico

Publications (1)

Publication Number Publication Date
IT202200001853A1 true IT202200001853A1 (it) 2023-08-03

Family

ID=81384816

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000001853A IT202200001853A1 (it) 2022-02-03 2022-02-03 Composizioni probiotiche e loro uso per modulare l'attività infiammatoria di tipo allergico

Country Status (1)

Country Link
IT (1) IT202200001853A1 (it)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
WO2021024216A1 (en) * 2019-08-08 2021-02-11 Università Cattolica del Sacro Cuore Probiotic mixture
WO2022024023A1 (en) * 2020-07-31 2022-02-03 Roelmi HPC s.r.l. Probiotic compositions and their use to modulate immune systems

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
WO2021024216A1 (en) * 2019-08-08 2021-02-11 Università Cattolica del Sacro Cuore Probiotic mixture
WO2022024023A1 (en) * 2020-07-31 2022-02-03 Roelmi HPC s.r.l. Probiotic compositions and their use to modulate immune systems

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Advanced Pro-Veflora 50 Billion | Massage Schmidmair", 28 January 2021 (2021-01-28), XP055887890, Retrieved from the Internet <URL:http://web.archive.org/web/20210128090812/https://www.schmidmair.at/produkt/nahrungsergaenzungen/advanced-pro-veflora-50-billion> [retrieved on 20220207] *
CICERO ARRIGO F G ET AL: "Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial", EUROPEAN JOURNAL OF NUTRITION, vol. 60, no. 2, 16 May 2020 (2020-05-16), pages 655 - 663, XP037376916, ISSN: 1436-6207, DOI: 10.1007/S00394-020-02271-8 *
I. PRESTI ET AL: "Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 99, no. 13, 7 March 2015 (2015-03-07), pages 5613 - 5626, XP055200124, ISSN: 0175-7598, DOI: 10.1007/s00253-015-6482-8 *
MICHELOTTI ANGELA ET AL: "Efficacy of a probiotic supplement in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled clinical trial", EUROPEAN JOURNAL OF DERMATOLOGY., vol. 31, no. 2, 1 April 2021 (2021-04-01), FR, pages 225 - 232, XP055886899, ISSN: 1167-1122, DOI: 10.1684/ejd.2021.4019 *

Similar Documents

Publication Publication Date Title
CL2008002350A1 (es) Uso de lactobacillus rhamnosus cgmcc 1.3724 y/o lactobacillus rhamnosus ncc 4007 para apoyar la perdida de peso y/o manejo de peso en humanos y/o animales.
YU58701A (sh) Derivati tioamida
BRPI0811871A2 (pt) Composições agroquímicas ácidas bioativas e uso das mesmas
CO6450668A2 (es) 3h-imidazol[4,5-c]piridina-6-carboxamidas en calidad de agentes antiinflamatorios
EA201001821A1 (ru) Производные триазола, полезные для лечения заболеваний
EA200702638A1 (ru) Стабильная композиция (рецептура) с наночастицами ацетаминофена
IN2012MN02261A (it)
DE50301517D1 (de) Silanvernetzbare beschichtungsformulierungen
ECSP088452A (es) Composiciones y métodos para modular la hemostasia
BR112012009487A2 (pt) formulações de espessante estáveis
EA200300508A1 (ru) Противовоспалительные агенты
BRPI0813017A2 (pt) &#34; formulação líquida e uso de uma formulação líquida &#34;
ID23359A (id) Susunan-susunan permukaan padat yang tidak diseimbangkan dan diekstrusi serta metode untuk membuat dan menggunakan susunan tersebut
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell&#39;istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
DOP2003000565A (es) Esteres hidroxamato del acido n-(4-fenil sustituido)- antranilico
IT202200001853A1 (it) Composizioni probiotiche e loro uso per modulare l&#39;attività infiammatoria di tipo allergico
IT202200001859A1 (it) Composizioni probiotiche e loro uso per modulare l&#39;attività infiammatoria di tipo allergico
IL262195A (en) Methods and preparations for improving the anti-inflammatory effects of interleukin 10
MX2021000271A (es) Composiciones de esterquat.
IT1391663B1 (it) Uso di composti atti ad inibire l&#39; attivita&#39; dell&#39;enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono
BRPI0606745A2 (pt) pasta de dentes
AR062145A1 (es) Metoods y composiciones para aumentar el tropismo tisular de vectores adenovirales recombinantes
EA200601510A1 (ru) Производные фенилэтаноламина в качестве бета-2-агонистов
YU58601A (sh) Derivati fenilalaninola
ZA202208273B (en) A soap composition